Journal of HIV and AIDS Research

Pere Domingo

Pere Domingo
HIV/AIDS Program Director, Unit of Infectious Diseases, Hospital de la Santa Creu i Sant Pau
Barcelona, Spain


Dr. Pere Domingo is currently Senior Consultant and HIV/AIDS Program Director at the Infectious Diseases Unit of the Hospital de la Santa Creu i Sant Pau. He graduated with honours in the University of Barcelona in 1980 and achieved his PhD degree in the Autonomous University of Barcelona in 1993 (Magna cum laude). He has been devoted to infectious diseases and HIV infection since 1989. He has served as Head of the Infectious Diseases Department at Hospitals Universitaris Arnau de Vilanova & Santa María at Lleida, Spain in the years 2016-2017. He has been Associate Professor of Medicine at the Medicine School (Autonomous University of Barcelona) from 1994 to 2016. He was also Professor of Medicine at the University of Lleida in the years 2016 and 2017.He has authored or co-authored more than 700 scientific papers and more than 100 book chapters. He has been the speaker in more than 500 meetings or congresses and is currently reviewer for more than 60 international journals, international agencies, and international meetings and conferences. He is now member of 12 Editorial Boards of medical journals. Dr. Domingo is an expert member of the Spanish Medicines Agency and of the European Medicines Agency. His main research interests are antiretroviral therapy and its complications, especially fat redistribution syndromes, metabolic alterations, insulin resistance, cardiovascular risk, and early senescence, but also meningococcal disease and bacterial meningitis in adults. Dr. Domingo is the past President of the Spanish AIDS study group (2011-2013), of the Spanish Society of Infectious Diseases and Clinical Microbiology and past Coordinator of the Clinical Medicine and Epidemiology area for the Spanish National Evaluation Agency (ANEP) for the years 2014-2017.

Research Interest

Antiretroviral therapy and its complications, Fat redistribution syndromes, Metabolic alterations, Insulin resistance, Cardiovascular risk, Early senescence, Meningococcal disease and Bacterial meningitis in adults.